Disease | prostate cancer |
Symptom | C1332128|peritoneal carcinomatosis |
Sentences | 1 |
PubMedID- 24296400 | Introduction: to identify the risk factors, characteristics and prognosis of patients treated with docetaxel-based chemotherapy for peritoneal carcinomatosis due to metastatic castrate-resistant prostate cancer (mcrpc). |
Page: 1